T-lymphotropic retrovirus peptide
US5210181A · kind A · utility
10Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 23, 1992 |
| Grant date | May 11, 1993 |
| Priority date | — |
| Expiry date | Jan 23, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/221
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The instant invention relates to monoclonal antibodies, the cell lines producing those antibodies, the peptides that comprise the epitopes of those antibodies and assays using those antibodies and peptides for the detection of HIV-1 and HIV-2 gene products. In particular, the antibodies react with the p24/p26 capsid protein, the nonapeptide that comprises an HIV-1/HIV-2 conserved epitope is disclosed and a capture ELISA using a combination of three monoclonal antibodies that can detect simultaneously HIV-1 and HIV-2 is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.